In looking at RCE previous posts, and considering the Pasteur act has the potential to assist with security of future funding, Tuberculosis is yet another bacteria that is a likely candidate.
But like sepsis, it has a high cost to treat, possibly more than sepsis, maybe simpler to administer and potentially a smaller market for the risk/reward for RCE.
that is if the inhalant is successful.
I like the multiple fronts RCE has, is Pursuing and with IP on manufacturing, surely would limit potential competition for at the very least 10 years.
- Forums
- ASX - By Stock
- PASTEUR Act
In looking at RCE previous posts, and considering the Pasteur...
Featured News
Add RCE (ASX) to my watchlist
(20min delay)
|
|||||
Last
60.0¢ |
Change
0.020(3.45%) |
Mkt cap ! $122.3M |
Open | High | Low | Value | Volume |
60.0¢ | 60.0¢ | 60.0¢ | $1.739K | 2.898K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 2517 | 59.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
60.0¢ | 2102 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 2517 | 0.590 |
4 | 19157 | 0.580 |
2 | 50880 | 0.575 |
1 | 33360 | 0.570 |
2 | 51000 | 0.560 |
Price($) | Vol. | No. |
---|---|---|
0.600 | 2102 | 1 |
0.605 | 7140 | 2 |
0.610 | 5000 | 1 |
0.630 | 2000 | 1 |
0.645 | 50629 | 2 |
Last trade - 10.41am 24/05/2024 (20 minute delay) ? |
|
|||||
Last
58.0¢ |
  |
Change
0.020 ( 0.00 %) |
|||
Open | High | Low | Volume | ||
59.0¢ | 59.0¢ | 58.0¢ | 5721 | ||
Last updated 11.06am 24/05/2024 ? |
Featured News
RCE (ASX) Chart |